acquisition
ADF GROUP INC., $5.27, symbol DRX on Toronto, designs and engineers connections, fabrication, heavy steel built-ups, and miscellaneous and architectural metalwork. It provides its services from a 630,000-square-foot fabrication plant in Quebec and a 100,000-square-foot fabrication plant in Montana.
The company’s clients include general contractors, project owners, engineering firms and project architects, structural steel erectors, and other steel structure fabricators....
The company’s clients include general contractors, project owners, engineering firms and project architects, structural steel erectors, and other steel structure fabricators....
CGI INC., $137.75, Toronto symbol GIB.A, is your #1 Aggressive Buy for 2023.
The stock lets investors tap Canada’s largest provider of computer outsourcing services. It helps its clients automate certain routine functions like accounting and buying supplies....
The stock lets investors tap Canada’s largest provider of computer outsourcing services. It helps its clients automate certain routine functions like accounting and buying supplies....
CAE recently agreed to sell its healthcare business, which makes medical-simulators and mannequins for training health professionals. That will let it better focus on its main flight simulator and pilot-training operations, particularly as the global air travel industry will need 1.3 million new pilots, aircraft maintenance technicians and cabin crew over the next 10 years....
Royal Bank’s shares are down roughly 17% from their recent peak of $140 in February 2023. That’s mainly due to fears that higher interest rates will hurt new loan demand and lead to more writedowns of its current loans.
However, banking regulators have toughened lending standards and mortgage stress-test levels in the past few years....
However, banking regulators have toughened lending standards and mortgage stress-test levels in the past few years....
We continue to recommend all investors maintain some exposure to the Resources sector—typically about 20% of your total portfolio. That’s mainly because resource stocks act as a hedge against inflation.
To further cut your risk, investors should stick with producers, such as the three we analyze below, with large reserves and low-cost operations....
To further cut your risk, investors should stick with producers, such as the three we analyze below, with large reserves and low-cost operations....
Understanding the Shift from Growth by Acquisition to Strategic Acquisitions in Today’s Market Landscape. Keep reading for more.
MASONITE INTERNATIONAL CORP., $86.83, symbol DOOR on New York, is a maker of interior and exterior doors for new construction as well as renovation and remodelling. The company’s client list has grown to more than 6,500 customers worldwide since operations started in 1925....
CANADIAN NATIONAL RAILWAY CO., $151.77, Toronto symbol CNR, remains a buy.
CN’s 32,200-kilometre network stretches across the country. It also travels down through the U.S. Midwest, connecting Canada to the Gulf of Mexico.
With the March 2023 payment, CN raised your quarterly dividend by 7.8%....
CN’s 32,200-kilometre network stretches across the country. It also travels down through the U.S. Midwest, connecting Canada to the Gulf of Mexico.
With the March 2023 payment, CN raised your quarterly dividend by 7.8%....
Camadian Pacific Kansas City and IBM are leading competitors in their respective markets. We still see both stocks as buys.
CANADIAN PACIFIC KANSAS CITY, $99.32, is a buy. The company (Toronto symbol CP; shares outstanding: 931.8 million; Market cap: $92.6 billion; Rating: Above Average; Dividend yield: 0.8%) ships freight over a 32,190-kilometre rail network....
CANADIAN PACIFIC KANSAS CITY, $99.32, is a buy. The company (Toronto symbol CP; shares outstanding: 931.8 million; Market cap: $92.6 billion; Rating: Above Average; Dividend yield: 0.8%) ships freight over a 32,190-kilometre rail network....
MERCK & CO. INC., $102.82, is a buy. The drugmaker (symbol MRK on New York) is a pharmaceutical leader in oncology, acute-care and animal health drugs as well as vaccines.
Merck continues to make savvy acquisitions. Most recently, it bought Prometheus Biosciences Inc....
Merck continues to make savvy acquisitions. Most recently, it bought Prometheus Biosciences Inc....